| NCT03361956 |
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03361956 |
Active, not recruiting |
Janssen Sciences Ireland UC |
2019-09-05 |
| NCT03389997 |
Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients |
https://ClinicalTrials.gov/show/NCT03389997 |
Recruiting |
Poitiers University Hospital |
2021-01-09 |
| NCT03369327 |
Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus |
https://ClinicalTrials.gov/show/NCT03369327 |
Completed |
Tehran University of Medical Sciences |
2018-09-01 |
| NCT04310228 |
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04310228 |
Recruiting |
Peking University First Hospital |
2020-05-31 |
| NCT03800173 |
A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430 |
https://ClinicalTrials.gov/show/NCT03800173 |
Active, not recruiting |
BioCryst Pharmaceuticals |
2019-04-30 |
| NCT03357757 |
Avelumab With Valproic Acid in Virus-associated Cancer |
https://ClinicalTrials.gov/show/NCT03357757 |
Recruiting |
AHS Cancer Control Alberta |
2022-03-30 |
| NCT03343626 |
Safety, Immunogenicity and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Adult Participants |
https://ClinicalTrials.gov/show/NCT03343626 |
Active, not recruiting |
Takeda |
2018-12-28 |
| NCT03336086 |
Effect of Weight Reduction on Immunity |
https://ClinicalTrials.gov/show/NCT03336086 |
Completed |
Shiraz University of Medical Sciences |
2012-11-30 |
| NCT03334695 |
An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults |
https://ClinicalTrials.gov/show/NCT03334695 |
Completed |
Janssen Vaccines & Prevention B.V. |
2018-07-10 |
| NCT03332459 |
A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection |
https://ClinicalTrials.gov/show/NCT03332459 |
Completed |
Janssen Research & Development, LLC |
2020-04-13 |
| NCT03321968 |
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03321968 |
Completed |
Medicago |
2017-12-01 |
| NCT03312023 |
Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03312023 |
Recruiting |
University of Maryland, Baltimore |
2020-08-31 |
| NCT03301051 |
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT03301051 |
Completed |
Medicago |
2018-05-02 |
| NCT03294473 |
Centralized Reminder Recall - Flu RCT2 |
https://ClinicalTrials.gov/show/NCT03294473 |
Completed |
University of California, Los Angeles |
2018-04-19 |
| NCT03294135 |
The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals’ Encepur Adults Vaccine |
https://ClinicalTrials.gov/show/NCT03294135 |
Active, not recruiting |
GlaxoSmithKline |
2022-07-14 |
| NCT03258502 |
Safety, Pharmacokinetics and Antiviral Activity of RV521 Against RSV |
https://ClinicalTrials.gov/show/NCT03258502 |
Completed |
ReViral Ltd |
2017-10-31 |
| NCT03250910 |
Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients |
https://ClinicalTrials.gov/show/NCT03250910 |
Completed |
National Taiwan University Hospital |
2017-07-15 |
| NCT03206346 |
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o. |
https://ClinicalTrials.gov/show/NCT03206346 |
Completed |
Valenta Pharm JSC |
2012-11-30 |
| NCT03191097 |
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o. |
https://ClinicalTrials.gov/show/NCT03191097 |
Completed |
Valenta Pharm JSC |
2014-12-31 |
| NCT03189537 |
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections |
https://ClinicalTrials.gov/show/NCT03189537 |
Completed |
Valenta Pharm JSC |
2011-04-19 |
| NCT03180216 |
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03180216 |
Recruiting |
Children’s National Research Institute |
2020-07-31 |
| NCT03166943 |
the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function |
https://ClinicalTrials.gov/show/NCT03166943 |
Recruiting |
Assiut University |
2020-12-31 |
| NCT03163628 |
biomArkers to differeNtiate bacTerial From vIral iNfEctions |
https://ClinicalTrials.gov/show/NCT03163628 |
Completed |
Hospices Civils de Lyon |
2019-06-12 |
| NCT03161366 |
Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine |
https://ClinicalTrials.gov/show/NCT03161366 |
Completed |
Epicentre |
2018-07-14 |
| NCT03154515 |
Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults |
https://ClinicalTrials.gov/show/NCT03154515 |
Completed |
Valenta Pharm JSC |
2014-04-30 |
| NCT03119025 |
Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection |
https://ClinicalTrials.gov/show/NCT03119025 |
Completed |
Russian Academy of Medical Sciences |
2018-02-28 |
| NCT03110770 |
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents |
https://ClinicalTrials.gov/show/NCT03110770 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-10-04 |
| NCT03079609 |
The Search for Viral and Bacterial Etiology of Varicocele |
https://ClinicalTrials.gov/show/NCT03079609 |
Active, not recruiting |
Medical University of Warsaw |
2019-12-31 |
| NCT03072030 |
International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi |
https://ClinicalTrials.gov/show/NCT03072030 |
Active, not recruiting |
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation |
2019-12-31 |
| NCT03051386 |
Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03051386 |
Active, not recruiting |
U.S. Army Medical Research and Development Command |
2022-04-01 |
| NCT03039621 |
Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children |
https://ClinicalTrials.gov/show/NCT03039621 |
Completed |
Materia Medica Holding |
2019-01-09 |
| NCT02996682 |
Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02996682 |
Completed |
Gilead Sciences |
2018-02-13 |
| NCT02993250 |
A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive |
https://ClinicalTrials.gov/show/NCT02993250 |
Completed |
Janssen Pharmaceutical K.K. |
2018-05-07 |
| NCT02991872 |
A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children |
https://ClinicalTrials.gov/show/NCT02991872 |
Completed |
GlaxoSmithKline |
2017-03-12 |
| NCT02968173 |
A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus |
https://ClinicalTrials.gov/show/NCT02968173 |
Completed |
AbbVie |
2017-07-13 |
| NCT02876328 |
Partnership for Research on Ebola VACcinations |
https://ClinicalTrials.gov/show/NCT02876328 |
Active, not recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-05-01 |
| NCT02847156 |
Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis. |
https://ClinicalTrials.gov/show/NCT02847156 |
Completed |
Hospices Civils de Lyon |
2016-01-31 |
| NCT02831751 |
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults |
https://ClinicalTrials.gov/show/NCT02831751 |
Completed |
Medicago |
2016-07-31 |
| NCT02825212 |
Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia |
https://ClinicalTrials.gov/show/NCT02825212 |
Completed |
Icahn School of Medicine at Mount Sinai |
2019-07-19 |
| NCT02822794 |
Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen |
https://ClinicalTrials.gov/show/NCT02822794 |
Completed |
Gilead Sciences |
2017-06-02 |
| NCT02781571 |
Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant |
https://ClinicalTrials.gov/show/NCT02781571 |
Completed |
Gilead Sciences |
2017-07-28 |
| NCT02776761 |
A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine |
https://ClinicalTrials.gov/show/NCT02776761 |
Recruiting |
U.S. Army Medical Research and Development Command |
2020-11-30 |
| NCT02768805 |
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02768805 |
Completed |
Medicago |
2016-05-17 |
| NCT02765802 |
A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection |
https://ClinicalTrials.gov/show/NCT02765802 |
Completed |
Eiger BioPharmaceuticals |
2018-06-20 |
| NCT02738138 |
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) |
https://ClinicalTrials.gov/show/NCT02738138 |
Completed |
AbbVie |
2017-03-15 |
| NCT02733068 |
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. |
https://ClinicalTrials.gov/show/NCT02733068 |
Active, not recruiting |
Shanghai Zerun Biotechnology Co.,Ltd |
2018-12-31 |
| NCT02723084 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02723084 |
Completed |
AbbVie |
2017-01-19 |
| NCT02722837 |
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02722837 |
Completed |
Gilead Sciences |
2017-06-26 |
| NCT02718469 |
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02718469 |
Completed |
Auro Vaccines LLC |
2016-09-15 |
| NCT02716428 |
A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02716428 |
Completed |
Trek Therapeutics, PBC |
2017-09-30 |
| NCT02707952 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02707952 |
Completed |
AbbVie |
2016-11-14 |
| NCT02662855 |
Efficacy of Favipiravir Against Severe Ebola Virus Disease |
https://ClinicalTrials.gov/show/NCT02662855 |
Completed |
Beijing Institute of Pharmacology and Toxicology |
2015-04-30 |
| NCT02654171 |
Viral Inhibition in Children for Treatment of RSV |
https://ClinicalTrials.gov/show/NCT02654171 |
Completed |
Ark Biosciences Inc. |
2019-03-31 |
| NCT02644018 |
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. |
https://ClinicalTrials.gov/show/NCT02644018 |
Completed |
Valenta Pharm JSC |
2016-05-31 |
| NCT02640157 |
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection |
https://ClinicalTrials.gov/show/NCT02640157 |
Completed |
AbbVie |
2016-10-31 |
| NCT02630082 |
Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru |
https://ClinicalTrials.gov/show/NCT02630082 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-03-31 |
| NCT02609659 |
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02609659 |
Completed |
AbbVie |
2016-10-07 |
| NCT02593162 |
A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02593162 |
Completed |
Trek Therapeutics, PBC |
2016-12-31 |
| NCT03309020 |
PREVAIL VII: Persistence of Ebola Virus in Aqueous Humor and Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease |
https://ClinicalTrials.gov/show/NCT03309020 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-08-01 |
| NCT02575456 |
A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine |
https://ClinicalTrials.gov/show/NCT02575456 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2016-06-30 |
| NCT02570126 |
A Safety and Immune Study of 2 Types of GlaxoSmithKline’s Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. |
https://ClinicalTrials.gov/show/NCT02570126 |
Completed |
GlaxoSmithKline |
2016-10-25 |
| NCT02558803 |
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 |
https://ClinicalTrials.gov/show/NCT02558803 |
Completed |
Regenstrief Institute, Inc. |
2016-05-31 |
| NCT02932150 |
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT02932150 |
Recruiting |
Gilead Sciences |
2023-02-28 |
| NCT02509494 |
Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo |
https://ClinicalTrials.gov/show/NCT02509494 |
Completed |
Janssen Vaccines & Prevention B.V. |
2019-06-28 |
| NCT02551887 |
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts |
https://ClinicalTrials.gov/show/NCT02551887 |
Completed |
Regenstrief Institute, Inc. |
2015-04-30 |
| NCT02548078 |
A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children |
https://ClinicalTrials.gov/show/NCT02548078 |
Completed |
GlaxoSmithKline |
2017-05-15 |
| NCT02546752 |
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine |
https://ClinicalTrials.gov/show/NCT02546752 |
Completed |
Regenstrief Institute, Inc. |
2016-05-31 |
| NCT02545517 |
A Clinical Study to Evaluate Immune Responses to Rabies Vaccine in Adults Who Received Different Primary Rabies Vaccination Regimens |
https://ClinicalTrials.gov/show/NCT02545517 |
Active, not recruiting |
GlaxoSmithKline |
2022-12-05 |
| NCT02534350 |
Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection |
https://ClinicalTrials.gov/show/NCT02534350 |
Completed |
Gilead Sciences |
2017-02-20 |
| NCT02533791 |
A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization |
https://ClinicalTrials.gov/show/NCT02533791 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2015-09-30 |
| NCT02532452 |
Third Party Anti-Viral Cytotoxic T-Cells |
https://ClinicalTrials.gov/show/NCT02532452 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2021-08-31 |
| NCT02510417 |
Allogeneic Virus-specific T Cell Lines (VSTs) |
https://ClinicalTrials.gov/show/NCT02510417 |
Recruiting |
Children’s National Research Institute |
2020-08-31 |
| NCT02510404 |
Multivirus-specific Cytotoxic T Lymphocytes (mCTL) |
https://ClinicalTrials.gov/show/NCT02510404 |
Completed |
Children’s National Research Institute |
2019-05-08 |
| NCT02495246 |
A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV |
https://ClinicalTrials.gov/show/NCT02495246 |
Completed |
University of Oxford |
2017-08-22 |
| NCT02491463 |
A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals’ RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02491463 |
Completed |
GlaxoSmithKline |
2016-04-08 |
| NCT02485912 |
Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination |
https://ClinicalTrials.gov/show/NCT02485912 |
Completed |
University of Oxford |
2016-01-31 |
| NCT02485301 |
A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT02485301 |
Completed |
GlaxoSmithKline |
2016-12-23 |
| NCT02479698 |
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus |
https://ClinicalTrials.gov/show/NCT02479698 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-31 |
| NCT02472548 |
A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine |
https://ClinicalTrials.gov/show/NCT02472548 |
Completed |
Dalhousie University |
2017-03-14 |
| NCT02469298 |
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza |
https://ClinicalTrials.gov/show/NCT02469298 |
Completed |
GlaxoSmithKline |
2016-04-25 |
| NCT02447705 |
Replacement of Lamivudine by Telbivudine to Improve Renal Function |
https://ClinicalTrials.gov/show/NCT02447705 |
Completed |
Chang Gung Memorial Hospital |
2016-12-31 |
| NCT02416453 |
A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02416453 |
Completed |
Janssen Vaccines & Prevention B.V. |
2018-01-19 |
| NCT02401373 |
A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China. |
https://ClinicalTrials.gov/show/NCT02401373 |
Completed |
First Affiliated Hospital of Zhejiang University |
2015-07-31 |
| NCT02387606 |
Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection. |
https://ClinicalTrials.gov/show/NCT02387606 |
Completed |
Janssen Sciences Ireland UC |
2015-09-21 |
| NCT02368119 |
Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO) |
https://ClinicalTrials.gov/show/NCT02368119 |
Completed |
University of Maryland, Baltimore |
2016-09-27 |
| NCT02351180 |
Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients |
https://ClinicalTrials.gov/show/NCT02351180 |
Active, not recruiting |
Washington University School of Medicine |
2021-04-30 |
| NCT02350569 |
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting |
https://ClinicalTrials.gov/show/NCT02350569 |
Completed |
Gilead Sciences |
2016-03-28 |
| NCT02342171 |
Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea |
https://ClinicalTrials.gov/show/NCT02342171 |
Completed |
Institute of Tropical Medicine, Belgium |
2015-07-31 |
| NCT02337868 |
Phase 1 Trial of Inactivated West Nile Virus Vaccine |
https://ClinicalTrials.gov/show/NCT02337868 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-12-16 |
| NCT02336139 |
A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use |
https://ClinicalTrials.gov/show/NCT02336139 |
Completed |
Kirby Institute |
2017-04-17 |
| NCT02329054 |
Efficacy of Favipiravir Against Ebola (JIKI) |
https://ClinicalTrials.gov/show/NCT02329054 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2015-05-31 |
| NCT02326194 |
A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. |
https://ClinicalTrials.gov/show/NCT02326194 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2015-02-28 |
| NCT02309918 |
HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02309918 |
Completed |
HepNet Study House, German Liverfoundation |
2016-08-31 |
| NCT02295501 |
A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease |
https://ClinicalTrials.gov/show/NCT02295501 |
Enrolling by invitation |
Cerus Corporation |
2020-12-31 |
| NCT02292719 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02292719 |
Completed |
AbbVie |
2017-07-14 |
| NCT02290340 |
A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants |
https://ClinicalTrials.gov/show/NCT02290340 |
Completed |
MedImmune LLC |
2016-09-28 |
| NCT02267109 |
Phase 1 Trial of Ebola Vaccine in Mali |
https://ClinicalTrials.gov/show/NCT02267109 |
Completed |
University of Maryland, Baltimore |
2016-04-20 |
| NCT02254707 |
Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection |
https://ClinicalTrials.gov/show/NCT02254707 |
Completed |
Boehringer Ingelheim |
2006-04-30 |
| NCT02253550 |
Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02253550 |
Completed |
Peter J. Ruane, M.D., Inc. |
2016-01-31 |
| NCT02250807 |
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02250807 |
Completed |
Janssen R&D Ireland |
2015-12-31 |
| NCT02250274 |
Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT02250274 |
Completed |
Marshfield Clinic Research Foundation |
2014-12-31 |
| NCT02236052 |
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population |
https://ClinicalTrials.gov/show/NCT02236052 |
Completed |
Medicago |
2015-06-17 |
| NCT02233816 |
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT02233816 |
Completed |
Medicago |
2015-06-22 |
| NCT02226952 |
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02226952 |
Completed |
Boehringer Ingelheim |
2002-04-30 |
| NCT02219477 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02219477 |
Completed |
AbbVie |
2016-06-13 |
| NCT02185794 |
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02185794 |
Completed |
Gilead Sciences |
2014-12-31 |
| NCT02183753 |
Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers |
https://ClinicalTrials.gov/show/NCT02183753 |
Completed |
University of North Carolina, Chapel Hill |
2015-03-31 |
| NCT02115815 |
A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults |
https://ClinicalTrials.gov/show/NCT02115815 |
Completed |
MedImmune LLC |
2015-06-30 |
| NCT02114385 |
A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) |
https://ClinicalTrials.gov/show/NCT02114385 |
Completed |
Merck Sharp & Dohme Corp. |
2015-04-22 |
| NCT02114177 |
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis |
https://ClinicalTrials.gov/show/NCT02114177 |
Completed |
Janssen Infectious Diseases BVBA |
2015-01-31 |
| NCT02114151 |
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis |
https://ClinicalTrials.gov/show/NCT02114151 |
Completed |
Janssen Infectious Diseases BVBA |
2015-01-31 |
| NCT02108522 |
Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT02108522 |
Completed |
AlloVir |
2018-01-31 |
| NCT02103023 |
Intradermal Influenza Vaccine in the Young |
https://ClinicalTrials.gov/show/NCT02103023 |
Completed |
The University of Hong Kong |
2014-11-30 |
| NCT02072174 |
Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children |
https://ClinicalTrials.gov/show/NCT02072174 |
Completed |
Materia Medica Holding |
2018-04-16 |
| NCT02061358 |
Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02061358 |
Completed |
Unither Virology |
2015-07-31 |
| NCT01316237 |
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01316237 |
Completed |
Gilead Sciences |
2011-10-31 |
| NCT01308424 |
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection |
https://ClinicalTrials.gov/show/NCT01308424 |
Completed |
Beech Tree Labs, Inc. |
2012-10-31 |
| NCT01273246 |
Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children |
https://ClinicalTrials.gov/show/NCT01273246 |
Completed |
Sinovac Biotech Co., Ltd |
2011-06-30 |
| NCT01273233 |
Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT01273233 |
Completed |
Sinovac Biotech Co., Ltd |
2011-02-28 |
| NCT02048332 |
Anti-viral Treatment Following Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT02048332 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2023-03-31 |
| NCT03959488 |
A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children |
https://ClinicalTrials.gov/show/NCT03959488 |
Recruiting |
MedImmune LLC |
2022-12-02 |
| NCT02013934 |
Probiotics in Prevention of Common Cold |
https://ClinicalTrials.gov/show/NCT02013934 |
Completed |
Probi AB |
2016-05-31 |
| NCT02012998 |
Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA |
https://ClinicalTrials.gov/show/NCT02012998 |
Completed |
Sanofi |
2015-02-28 |
| NCT02007356 |
A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® |
https://ClinicalTrials.gov/show/NCT02007356 |
Recruiting |
University Hospital, Basel, Switzerland |
2020-12-31 |
| NCT02003703 |
Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . |
https://ClinicalTrials.gov/show/NCT02003703 |
Completed |
Universidad de Valparaiso |
2018-06-30 |
| NCT01991587 |
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT01991587 |
Completed |
Medicago |
2014-06-30 |
| NCT01991561 |
Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. |
https://ClinicalTrials.gov/show/NCT01991561 |
Completed |
Medicago |
2014-07-31 |
| NCT01957878 |
Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL |
https://ClinicalTrials.gov/show/NCT01957878 |
Completed |
Genticel |
2016-10-31 |
| NCT01939197 |
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection |
https://ClinicalTrials.gov/show/NCT01939197 |
Completed |
AbbVie |
2016-07-21 |
| NCT01924117 |
Genotypification and Predisposing Factors in Human Papilloma Virus Infection |
https://ClinicalTrials.gov/show/NCT01924117 |
Completed |
Materno-Perinatal Hospital of the State of Mexico |
2011-05-31 |
| NCT01892358 |
Preventing Bacterial and Viral Infections Among Injection Drug Users |
https://ClinicalTrials.gov/show/NCT01892358 |
Completed |
Butler Hospital |
2019-08-31 |
| NCT01883180 |
ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis |
https://ClinicalTrials.gov/show/NCT01883180 |
Completed |
Nanfang Hospital of Southern Medical University |
2017-09-30 |
| NCT01854697 |
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before |
https://ClinicalTrials.gov/show/NCT01854697 |
Completed |
AbbVie |
2014-11-30 |
| NCT01842997 |
Safety of H1N1 Influenza Vaccination in Pregnant Women |
https://ClinicalTrials.gov/show/NCT01842997 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2010-12-31 |
| NCT01839188 |
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) |
https://ClinicalTrials.gov/show/NCT01839188 |
Completed |
MCM Vaccines B.V. |
2014-03-19 |
| NCT01839175 |
Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination |
https://ClinicalTrials.gov/show/NCT01839175 |
Completed |
Sanofi |
2014-07-31 |
| NCT01819792 |
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia |
https://ClinicalTrials.gov/show/NCT01819792 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2016-07-31 |
| NCT01806103 |
Antimicrobial Stewardship for Primary Care Pediatricians |
https://ClinicalTrials.gov/show/NCT01806103 |
Completed |
Children’s Hospital of Philadelphia |
2011-06-30 |
| NCT01800071 |
A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT01800071 |
Completed |
Cancer Research UK |
2017-03-10 |
| NCT01724203 |
Effect of 12-week Probiotic Supplementation on Bacterial and Viral Infections in Infants Aged 6 to 12 Months. |
https://ClinicalTrials.gov/show/NCT01724203 |
Completed |
Fonterra Research Centre |
2013-04-30 |
| NCT01708889 |
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction |
https://ClinicalTrials.gov/show/NCT01708889 |
Completed |
Bristol-Myers Squibb |
2013-02-28 |
| NCT01689285 |
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir |
https://ClinicalTrials.gov/show/NCT01689285 |
Completed |
Radboud University |
2015-07-31 |
| NCT01685203 |
A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01685203 |
Completed |
AbbVie |
2014-06-30 |
| NCT01682109 |
Palatability Testing of a New Paediatric Formulation of Valacyclovir |
https://ClinicalTrials.gov/show/NCT01682109 |
Completed |
Radboud University |
2016-03-31 |
| NCT01672983 |
A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01672983 |
Completed |
AbbVie |
2014-05-31 |
| NCT01666782 |
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT01666782 |
Completed |
Rochester General Hospital |
2015-06-30 |
| NCT01624948 |
Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01624948 |
Completed |
University of California, San Francisco |
2015-02-28 |
| NCT01604746 |
Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 |
https://ClinicalTrials.gov/show/NCT01604746 |
Completed |
Ology Bioservices |
2013-04-30 |
| NCT01590654 |
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT01590654 |
Completed |
Gilead Sciences |
2013-11-30 |
| NCT01587131 |
DNA-based Influenza Vaccine in the Elderly |
https://ClinicalTrials.gov/show/NCT01587131 |
Completed |
University of Manitoba |
2014-08-31 |
| NCT01553279 |
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) |
https://ClinicalTrials.gov/show/NCT01553279 |
Completed |
MCM Vaccines B.V. |
2013-09-27 |
| NCT01546506 |
Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells |
https://ClinicalTrials.gov/show/NCT01546506 |
Completed |
Hospices Civils de Lyon |
2014-03-31 |
| NCT01502072 |
Respiratory Syncytial Virus - RSV Protocol |
https://ClinicalTrials.gov/show/NCT01502072 |
Completed |
M.D. Anderson Cancer Center |
2020-02-01 |
| NCT01494103 |
Administration of Donor T Cells With the Caspase-9 Suicide Gene |
https://ClinicalTrials.gov/show/NCT01494103 |
Active, not recruiting |
Baylor College of Medicine |
2029-05-31 |
| NCT01480258 |
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) |
https://ClinicalTrials.gov/show/NCT01480258 |
Completed |
MCM Vaccines B.V. |
2013-10-09 |
| NCT01466062 |
Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions |
https://ClinicalTrials.gov/show/NCT01466062 |
Completed |
AbbVie |
2012-04-30 |
| NCT01459081 |
Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China |
https://ClinicalTrials.gov/show/NCT01459081 |
Completed |
Jiangsu Simcere Pharmaceutical Co., Ltd. |
2012-12-31 |
| NCT01431898 |
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01431898 |
Completed |
Gilead Sciences |
2011-12-31 |
| NCT01421121 |
Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants |
https://ClinicalTrials.gov/show/NCT01421121 |
Completed |
Sinovac Biotech Co., Ltd |
2011-09-30 |
| NCT01396512 |
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEVâ„¢) Compared to CD.JEVAXâ„¢ in Toddlers |
https://ClinicalTrials.gov/show/NCT01396512 |
Completed |
Sanofi |
2013-03-31 |
| NCT01371578 |
Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01371578 |
Completed |
Gilead Sciences |
2013-03-31 |
| NCT01353339 |
Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study |
https://ClinicalTrials.gov/show/NCT01353339 |
Completed |
Ottawa Hospital Research Institute |
2014-04-30 |
| NCT01349543 |
The Development of a Human Model of Respiratory Syncytial Virus Infection |
https://ClinicalTrials.gov/show/NCT01349543 |
Completed |
Imperial College London |
2013-10-31 |
| NCT01347736 |
Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection |
https://ClinicalTrials.gov/show/NCT01347736 |
Completed |
Mayo Clinic |
2012-11-07 |
| NCT01341639 |
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) |
https://ClinicalTrials.gov/show/NCT01341639 |
Completed |
MCM Vaccines B.V. |
2013-03-13 |
| NCT01340937 |
A Study of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-006) |
https://ClinicalTrials.gov/show/NCT01340937 |
Completed |
Merck Sharp & Dohme Corp. |
2012-12-18 |
| NCT01337167 |
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-005) |
https://ClinicalTrials.gov/show/NCT01337167 |
Completed |
Merck Sharp & Dohme Corp. |
2013-05-09 |
| NCT01336010 |
Treatment of Recently Acquired Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01336010 |
Completed |
Kirby Institute |
2015-06-30 |
| NCT04414267 |
Bacillus Calmette-guérin Vaccination to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04414267 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2021-05-25 |
| NCT04403100 |
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” |
https://ClinicalTrials.gov/show/NCT04403100 |
Recruiting |
Cardresearch |
2020-09-03 |
| NCT04398004 |
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early |
https://ClinicalTrials.gov/show/NCT04398004 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2022-05-06 |
| NCT04380701 |
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04380701 |
Recruiting |
Biontech SE |
2020-08-31 |
| NCT04376034 |
Convalescent Plasma Collection and Treatment in Pediatrics and Adults |
https://ClinicalTrials.gov/show/NCT04376034 |
Recruiting |
West Virginia University |
2021-03-30 |
| NCT04365101 |
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) |
https://ClinicalTrials.gov/show/NCT04365101 |
Recruiting |
Celularity Incorporated |
2020-11-30 |
| NCT04363411 |
Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections |
https://ClinicalTrials.gov/show/NCT04363411 |
Completed |
Hasselt University |
2019-10-22 |
| NCT04348864 |
COVID-19 Antibody Self-testing Using Virtual Point-of-care |
https://ClinicalTrials.gov/show/NCT04348864 |
Recruiting |
Neuroganics LLC |
2021-04-30 |
| NCT04333589 |
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive |
https://ClinicalTrials.gov/show/NCT04333589 |
Recruiting |
Peking University First Hospital |
2020-06-01 |
| NCT04326790 |
The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention |
https://ClinicalTrials.gov/show/NCT04326790 |
Recruiting |
National and Kapodistrian University of Athens |
2020-08-31 |
| NCT04322773 |
Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04322773 |
Recruiting |
Frederiksberg University Hospital |
2021-06-01 |
| NCT04322396 |
Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04322396 |
Recruiting |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
2020-10-31 |
| NCT04316377 |
Norwegian Coronavirus Disease 2019 Study |
https://ClinicalTrials.gov/show/NCT04316377 |
Active, not recruiting |
University Hospital, Akershus |
2020-05-25 |
| NCT04308317 |
Tetrandrine Tablets Used in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04308317 |
Enrolling by invitation |
Henan Provincial People’s Hospital |
2021-03-01 |
| NCT04293042 |
Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients |
https://ClinicalTrials.gov/show/NCT04293042 |
Recruiting |
Children’s Hospital of Philadelphia |
2022-12-30 |
| NCT04288102 |
Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04288102 |
Active, not recruiting |
Beijing 302 Hospital |
2020-05-12 |
| NCT04258059 |
Wells and Enteric Disease Transmission Trial (WET - Trial) |
https://ClinicalTrials.gov/show/NCT04258059 |
Recruiting |
Temple University |
2021-06-30 |
| NCT04248426 |
A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04248426 |
Recruiting |
Antios Therapeutics, Inc |
2021-08-31 |
| NCT04244084 |
Clinical Trial of Efficacy and Safety of ММÐ-407 in Acute Respiratory Viral Infection |
https://ClinicalTrials.gov/show/NCT04244084 |
Completed |
Materia Medica Holding |
2020-04-09 |
| NCT04186000 |
Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola |
https://ClinicalTrials.gov/show/NCT04186000 |
Recruiting |
Universiteit Antwerpen |
2022-07-18 |
| NCT04156217 |
EBV-TCR-T Cells for EB Virus Infection After HSCT |
https://ClinicalTrials.gov/show/NCT04156217 |
Recruiting |
Hebei Yanda Ludaopei Hospital |
2021-11-01 |
| NCT04153279 |
CMV-TCR-T Cells for CM Virus Infection After HSCT |
https://ClinicalTrials.gov/show/NCT04153279 |
Recruiting |
Hebei Yanda Ludaopei Hospital |
2021-10-01 |
| NCT04152486 |
Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC |
https://ClinicalTrials.gov/show/NCT04152486 |
Recruiting |
London School of Hygiene and Tropical Medicine |
2020-11-30 |
| NCT04141930 |
Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle |
https://ClinicalTrials.gov/show/NCT04141930 |
Enrolling by invitation |
University of Washington |
2020-05-01 |
| NCT04141917 |
Test-and-treat for Influenza in Homeless Shelters |
https://ClinicalTrials.gov/show/NCT04141917 |
Recruiting |
University of Washington |
2021-04-30 |
| NCT04139681 |
Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats |
https://ClinicalTrials.gov/show/NCT04139681 |
Active, not recruiting |
Bioforce AG |
2019-04-26 |
| NCT04129554 |
A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04129554 |
Recruiting |
Janssen Sciences Ireland UC |
2022-01-31 |
| NCT04124198 |
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04124198 |
Recruiting |
Rigshospitalet, Denmark |
2024-01-31 |
| NCT04111367 |
Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients |
https://ClinicalTrials.gov/show/NCT04111367 |
Recruiting |
Ginkgopharma CO., LTD |
2020-04-30 |
| NCT04086472 |
Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of MK-1654 in Healthy Participants (MK-1654-005) |
https://ClinicalTrials.gov/show/NCT04086472 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2020-03-22 |
| NCT04081480 |
Pharmacokinetics of Valacyclovir Oral Solution in Children |
https://ClinicalTrials.gov/show/NCT04081480 |
Recruiting |
Radboud University |
2020-09-01 |
| NCT04062669 |
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals’ Experimental Rabies Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04062669 |
Recruiting |
GlaxoSmithKline |
2020-04-29 |
| NCT04056611 |
Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) |
https://ClinicalTrials.gov/show/NCT04056611 |
Recruiting |
Janssen Sciences Ireland UC |
2022-08-15 |
| NCT04055454 |
A Trial to Evaluate the Optimal Dose of MV-LASV |
https://ClinicalTrials.gov/show/NCT04055454 |
Recruiting |
Themis Bioscience GmbH |
2020-04-30 |
| NCT04046978 |
Modelling the Interaction Between Synthetic Model Immunogens and the Induced B and T Cell Repertoires. |
https://ClinicalTrials.gov/show/NCT04046978 |
Recruiting |
Imperial College London |
2020-09-30 |
| NCT04042740 |
Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT04042740 |
Active, not recruiting |
AIDS Clinical Trials Group |
2023-03-02 |
| NCT04028349 |
Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo) |
https://ClinicalTrials.gov/show/NCT04028349 |
Recruiting |
MRC/UVRI Uganda Research Unit on Aids |
2020-07-31 |
| NCT04008004 |
A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) |
https://ClinicalTrials.gov/show/NCT04008004 |
Active, not recruiting |
Enanta Pharmaceuticals |
2020-12-31 |
| NCT04001608 |
Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients |
https://ClinicalTrials.gov/show/NCT04001608 |
Active, not recruiting |
Ginkgopharma CO., LTD |
2019-07-31 |
| NCT03990766 |
Smell Changes & Efficacy of Nasal Theophylline |
https://ClinicalTrials.gov/show/NCT03990766 |
Recruiting |
Washington University School of Medicine |
2020-06-30 |
| NCT03982186 |
A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03982186 |
Recruiting |
Janssen Sciences Ireland UC |
2021-03-31 |
| NCT03981822 |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts |
https://ClinicalTrials.gov/show/NCT03981822 |
Recruiting |
Verrica Pharmaceuticals Inc. |
2020-08-12 |
| NCT03929757 |
A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants |
https://ClinicalTrials.gov/show/NCT03929757 |
Active, not recruiting |
Janssen Vaccines & Prevention B.V. |
2020-12-22 |
| NCT03916185 |
Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age |
https://ClinicalTrials.gov/show/NCT03916185 |
Recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-12-10 |
| NCT03891550 |
Micro-elimination of Hepatitis C Virus Infection in Uremics |
https://ClinicalTrials.gov/show/NCT03891550 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2024-04-15 |
| NCT03830905 |
Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI |
https://ClinicalTrials.gov/show/NCT03830905 |
Recruiting |
PHARMENTERPRISES LLC |
2020-01-31 |
| NCT03818334 |
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT03818334 |
Recruiting |
Hospital Israelita Albert Einstein |
2021-11-01 |
| NCT03769467 |
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) |
https://ClinicalTrials.gov/show/NCT03769467 |
Recruiting |
Atara Biotherapeutics |
2023-09-30 |
| NCT03762681 |
A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT03762681 |
Active, not recruiting |
Hoffmann-La Roche |
2021-03-13 |
| NCT03739112 |
Efficacy of a Plant-derived Quadrivalent VLP Vaccine in the Elderly |
https://ClinicalTrials.gov/show/NCT03739112 |
Completed |
Medicago |
2019-05-17 |
| NCT03719586 |
Investigational Therapeutics for the Treatment of People With Ebola Virus Disease |
https://ClinicalTrials.gov/show/NCT03719586 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2019-09-09 |
| NCT03718130 |
Combination HTNV and PUUV DNA Vaccine |
https://ClinicalTrials.gov/show/NCT03718130 |
Enrolling by invitation |
U.S. Army Medical Research and Development Command |
2020-05-31 |
| NCT03699202 |
Anti-RSV Study in Chinese Patients (ASCENT) |
https://ClinicalTrials.gov/show/NCT03699202 |
Recruiting |
Ark Biosciences Inc. |
2020-01-31 |
| NCT03684668 |
Psychoeduc Interv. Through Meta-universes on Condom`s Use Self - Efficacy and Sexual Behavior in Students of UAChile |
https://ClinicalTrials.gov/show/NCT03684668 |
Recruiting |
Universidad Autónoma de Chile |
2019-12-31 |
| NCT03674125 |
Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT03674125 |
Completed |
GeneOne Life Science, Inc. |
2020-04-07 |
| NCT03707912 |
Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections |
https://ClinicalTrials.gov/show/NCT03707912 |
Completed |
Materia Medica Holding |
2019-03-15 |
| NCT03624946 |
Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) |
https://ClinicalTrials.gov/show/NCT03624946 |
Completed |
Emergent BioSolutions |
2019-03-06 |
| NCT03615183 |
A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002) |
https://ClinicalTrials.gov/show/NCT03615183 |
Completed |
Merck Sharp & Dohme Corp. |
2019-09-26 |
| NCT03598452 |
High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients |
https://ClinicalTrials.gov/show/NCT03598452 |
Completed |
Aier School of Ophthalmology, Central South University |
2018-01-31 |
| NCT03594981 |
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis |
https://ClinicalTrials.gov/show/NCT03594981 |
Recruiting |
Children’s National Research Institute |
2021-07-31 |
| NCT03584308 |
Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal |
https://ClinicalTrials.gov/show/NCT03584308 |
Completed |
Catalysis SL |
2018-05-15 |
| NCT03487549 |
Cantharidin and Occlusion in Verruca Epithelium |
https://ClinicalTrials.gov/show/NCT03487549 |
Completed |
Verrica Pharmaceuticals Inc. |
2019-05-16 |
| NCT03475056 |
cAd3-Marburg Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03475056 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-12-19 |
| NCT03473002 |
A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03473002 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-02-14 |
| NCT03462004 |
Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein |
https://ClinicalTrials.gov/show/NCT03462004 |
Active, not recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-10-31 |
| NCT03455491 |
Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections |
https://ClinicalTrials.gov/show/NCT03455491 |
Completed |
PHARMENTERPRISES LLC |
2018-06-28 |
| NCT03441373 |
XC8 in the Treatment of Patients With Acute Respiratory Viral Infection |
https://ClinicalTrials.gov/show/NCT03441373 |
Completed |
PHARMENTERPRISES LLC |
2017-02-09 |
| NCT03425149 |
Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03425149 |
Completed |
Valneva Austria GmbH |
2018-06-26 |
| NCT01244867 |
Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine |
https://ClinicalTrials.gov/show/NCT01244867 |
Completed |
Medicago |
2011-07-31 |
| NCT01242670 |
Ross River Virus (RRV) Vaccine Study |
https://ClinicalTrials.gov/show/NCT01242670 |
Completed |
Ology Bioservices |
2012-10-31 |
| NCT01241760 |
VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01241760 |
Completed |
Janssen Infectious Diseases BVBA |
2012-08-31 |
| NCT01183611 |
The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates |
https://ClinicalTrials.gov/show/NCT01183611 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2010-06-30 |
| NCT01136395 |
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation |
https://ClinicalTrials.gov/show/NCT01136395 |
Completed |
University of Giessen |
2019-06-18 |
| NCT01097395 |
Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01097395 |
Completed |
University of Colorado, Denver |
2015-08-31 |
| NCT01096576 |
A Study of Balapiravir in Patients With Dengue Virus Infection |
https://ClinicalTrials.gov/show/NCT01096576 |
Completed |
Hoffmann-La Roche |
2011-04-30 |
| NCT01090232 |
Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection |
https://ClinicalTrials.gov/show/NCT01090232 |
Completed |
Assistance Publique Hopitaux De Marseille |
2012-02-29 |
| NCT01072695 |
Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01072695 |
Completed |
Gilead Sciences |
2010-10-31 |
| NCT02022163 |
Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. |
https://ClinicalTrials.gov/show/NCT02022163 |
Completed |
Medicago |
2014-09-30 |
| NCT01032408 |
Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection |
https://ClinicalTrials.gov/show/NCT01032408 |
Completed |
Chiltern Pesquisa Clinica Ltda |
2011-09-30 |
| NCT01021397 |
Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children |
https://ClinicalTrials.gov/show/NCT01021397 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-12-31 |
| NCT01006629 |
Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children |
https://ClinicalTrials.gov/show/NCT01006629 |
Completed |
Abbott |
2010-04-30 |
| NCT00997607 |
Evaluating an Ebola and a Marburg Vaccine in Uganda |
https://ClinicalTrials.gov/show/NCT00997607 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-04-30 |
| NCT00984945 |
Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00984945 |
Completed |
Medicago |
2009-12-31 |
| NCT00980447 |
Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults |
https://ClinicalTrials.gov/show/NCT00980447 |
Completed |
UMN Pharma Inc. |
2009-12-31 |
| NCT00975572 |
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older |
https://ClinicalTrials.gov/show/NCT00975572 |
Completed |
Jiangsu Province Centers for Disease Control and Prevention |
2009-09-30 |
| NCT00973284 |
Norwalk Vaccine Study |
https://ClinicalTrials.gov/show/NCT00973284 |
Completed |
Takeda |
2010-04-07 |
| NCT00949572 |
Measuring Responses to Sublingual Antigens |
https://ClinicalTrials.gov/show/NCT00949572 |
Completed |
St George’s, University of London |
2010-06-30 |
| NCT00948220 |
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00948220 |
Completed |
University of Ulm |
2007-01-31 |
| NCT00921726 |
Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00921726 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-10-31 |
| NCT00853255 |
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00853255 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-08-31 |
| NCT04369365 |
A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic |
https://ClinicalTrials.gov/show/NCT04369365 |
Recruiting |
Medical University of Vienna |
2020-08-27 |
| NCT04223037 |
Purified Inactivated Japanese Encephalitis Vaccine |
https://ClinicalTrials.gov/show/NCT04223037 |
Active, not recruiting |
Chinese Academy of Medical Sciences |
2018-03-07 |
| NCT04357366 |
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) |
https://ClinicalTrials.gov/show/NCT04357366 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2022-04-15 |
| NCT04339712 |
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction |
https://ClinicalTrials.gov/show/NCT04339712 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2022-04-01 |
| NCT03776994 |
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine |
https://ClinicalTrials.gov/show/NCT03776994 |
Active, not recruiting |
SRI International |
2020-07-31 |
| NCT02755948 |
A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers |
https://ClinicalTrials.gov/show/NCT02755948 |
Recruiting |
Imperial College London |
2020-09-30 |
| NCT02094365 |
A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model |
https://ClinicalTrials.gov/show/NCT02094365 |
Completed |
Alios Biopharma Inc. |
2014-06-30 |
| NCT04334265 |
Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04334265 |
Recruiting |
Peking University First Hospital |
2020-06-01 |
| NCT03463694 |
Edinburgh and Lothian Virus Intervention Study in Kids |
https://ClinicalTrials.gov/show/NCT03463694 |
Recruiting |
University of Edinburgh |
2020-05-31 |
| NCT03155906 |
Integrated Treatment of Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT03155906 |
Active, not recruiting |
Haukeland University Hospital |
2020-05-08 |
| NCT01805752 |
Optimizing Integrated PMTCT Services in Rural North-Central Nigeria |
https://ClinicalTrials.gov/show/NCT01805752 |
Completed |
Vanderbilt University |
2015-12-31 |
| NCT01570283 |
ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus |
https://ClinicalTrials.gov/show/NCT01570283 |
Completed |
AlloVir |
2016-08-31 |
| NCT03883906 |
Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03883906 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2023-03-31 |
| NCT00749580 |
A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen |
https://ClinicalTrials.gov/show/NCT00749580 |
Completed |
University of South Florida |
2011-07-31 |
| NCT00734175 |
Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine |
https://ClinicalTrials.gov/show/NCT00734175 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-12-31 |
| NCT00722774 |
Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine |
https://ClinicalTrials.gov/show/NCT00722774 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-09-30 |
| NCT00717834 |
Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine |
https://ClinicalTrials.gov/show/NCT00717834 |
Completed |
Ology Bioservices |
2008-10-31 |
| NCT00711009 |
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) |
https://ClinicalTrials.gov/show/NCT00711009 |
Completed |
Abbott |
2009-11-30 |
| NCT00707642 |
Safety Study of HBV-002 West Nile Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00707642 |
Completed |
Hawaii Biotech, Inc. |
2009-06-30 |
| NCT00668369 |
Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00668369 |
Completed |
Hospital Clinic of Barcelona |
2011-09-30 |
| NCT00641017 |
Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine |
https://ClinicalTrials.gov/show/NCT00641017 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-07-31 |
| NCT00605514 |
Ebola and Marburg Virus Vaccines |
https://ClinicalTrials.gov/show/NCT00605514 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-06-21 |
| NCT00575185 |
Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection |
https://ClinicalTrials.gov/show/NCT00575185 |
Completed |
University of Minnesota |
2009-07-31 |
| NCT00565539 |
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00565539 |
Completed |
ZymoGenetics |
2009-10-31 |
| NCT00551915 |
A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) |
https://ClinicalTrials.gov/show/NCT00551915 |
Completed |
Merck Sharp & Dohme Corp. |
2003-01-31 |
| NCT00551629 |
A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) |
https://ClinicalTrials.gov/show/NCT00551629 |
Completed |
Merck Sharp & Dohme Corp. |
2003-03-31 |
| NCT00516035 |
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00516035 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-12-31 |
| NCT00502086 |
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. |
https://ClinicalTrials.gov/show/NCT00502086 |
Completed |
Catalysis SL |
2009-07-31 |
| NCT00493285 |
Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age |
https://ClinicalTrials.gov/show/NCT00493285 |
Completed |
MedImmune LLC |
2009-11-30 |
| NCT00489931 |
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally |
https://ClinicalTrials.gov/show/NCT00489931 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00488046 |
Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00488046 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00444860 |
ZOSTAVAX(R) Local Registration Trial (V211-019) |
https://ClinicalTrials.gov/show/NCT00444860 |
Completed |
Merck Sharp & Dohme Corp. |
2007-05-31 |
| NCT00421304 |
A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness |
https://ClinicalTrials.gov/show/NCT00421304 |
Completed |
MedImmune LLC |
2010-01-31 |
| NCT00408109 |
Safety Study of Avian Flu Vaccine |
https://ClinicalTrials.gov/show/NCT00408109 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00395018 |
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT00395018 |
Completed |
Bristol-Myers Squibb |
2011-03-31 |
| NCT00383864 |
Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. |
https://ClinicalTrials.gov/show/NCT00383864 |
Completed |
Hospital Clinic of Barcelona |
NA |
| NCT00380237 |
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) |
https://ClinicalTrials.gov/show/NCT00380237 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-01-31 |
| NCT00374309 |
Experimental Vaccine for Prevention of Ebola Virus Infection |
https://ClinicalTrials.gov/show/NCT00374309 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00366782 |
Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults |
https://ClinicalTrials.gov/show/NCT00366782 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-02-28 |
| NCT00361101 |
A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus |
https://ClinicalTrials.gov/show/NCT00361101 |
Completed |
Sanofi |
2006-08-31 |
| NCT00347672 |
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00347672 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-07-31 |
| NCT00343278 |
Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets |
https://ClinicalTrials.gov/show/NCT00343278 |
Completed |
GlaxoSmithKline |
2005-08-31 |
| NCT00308412 |
Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants |
https://ClinicalTrials.gov/show/NCT00308412 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-04-30 |
| NCT00294918 |
An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome |
https://ClinicalTrials.gov/show/NCT00294918 |
Completed |
EMD Serono |
2003-02-28 |
| NCT00294164 |
Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) |
https://ClinicalTrials.gov/show/NCT00294164 |
Completed |
EMD Serono |
2002-05-31 |
| NCT00262522 |
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects |
https://ClinicalTrials.gov/show/NCT00262522 |
Completed |
Abbott |
2008-07-31 |
| NCT00248339 |
Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00248339 |
Completed |
Virginia Commonwealth University |
2005-07-31 |
| NCT00220597 |
Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse |
https://ClinicalTrials.gov/show/NCT00220597 |
Completed |
Stanford University |
2004-12-31 |
| NCT00219453 |
Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination |
https://ClinicalTrials.gov/show/NCT00219453 |
Completed |
PATH |
NA |
| NCT00209352 |
Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00209352 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00194480 |
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users |
https://ClinicalTrials.gov/show/NCT00194480 |
Completed |
National Institute on Drug Abuse (NIDA) |
2006-12-31 |
| NCT00186927 |
A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers |
https://ClinicalTrials.gov/show/NCT00186927 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2023-01-31 |
| NCT00180674 |
Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00180674 |
Completed |
Imperial College London |
2006-09-30 |
| NCT00110279 |
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) |
https://ClinicalTrials.gov/show/NCT00110279 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-09-30 |
| NCT00069316 |
Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease |
https://ClinicalTrials.gov/show/NCT00069316 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-06-27 |
| NCT00047814 |
Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00047814 |
Completed |
Astellas Pharma Inc |
NA |
| NCT00002358 |
A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV |
https://ClinicalTrials.gov/show/NCT00002358 |
Completed |
Bristol-Myers Squibb |
NA |
| NCT00002144 |
The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment |
https://ClinicalTrials.gov/show/NCT00002144 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002009 |
A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia |
https://ClinicalTrials.gov/show/NCT00002009 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002008 |
An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia |
https://ClinicalTrials.gov/show/NCT00002008 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002001 |
The Antiviral Efficacy of Concurrent Zidovudine and 2’,3’-Dideoxyinosine or 2’,3’-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease |
https://ClinicalTrials.gov/show/NCT00002001 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00000654 |
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU |
https://ClinicalTrials.gov/show/NCT00000654 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001386 |
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection |
https://ClinicalTrials.gov/show/NCT00001386 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |